GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofil Chemicals & Pharmaceuticals Ltd (BOM:524396) » Definitions » Shiller PE Ratio

Biofil Chemicals & Pharmaceuticals (BOM:524396) Shiller PE Ratio : 91.08 (As of May. 15, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Biofil Chemicals & Pharmaceuticals Shiller PE Ratio?

As of today (2024-05-15), Biofil Chemicals & Pharmaceuticals's current share price is ₹67.40. Biofil Chemicals & Pharmaceuticals's E10 for the quarter that ended in Dec. 2023 was ₹0.74. Biofil Chemicals & Pharmaceuticals's Shiller PE Ratio for today is 91.08.

The historical rank and industry rank for Biofil Chemicals & Pharmaceuticals's Shiller PE Ratio or its related term are showing as below:

BOM:524396' s Shiller PE Ratio Range Over the Past 10 Years
Min: 54.41   Med: 84.35   Max: 472.82
Current: 92.46

During the past years, Biofil Chemicals & Pharmaceuticals's highest Shiller PE Ratio was 472.82. The lowest was 54.41. And the median was 84.35.

BOM:524396's Shiller PE Ratio is ranked worse than
91.35% of 532 companies
in the Drug Manufacturers industry
Industry Median: 25.285 vs BOM:524396: 92.46

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Biofil Chemicals & Pharmaceuticals's adjusted earnings per share data for the three months ended in Dec. 2023 was ₹0.060. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₹0.74 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Biofil Chemicals & Pharmaceuticals Shiller PE Ratio Historical Data

The historical data trend for Biofil Chemicals & Pharmaceuticals's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofil Chemicals & Pharmaceuticals Shiller PE Ratio Chart

Biofil Chemicals & Pharmaceuticals Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 87.81 83.89 57.69

Biofil Chemicals & Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 74.15 57.69 59.20 63.58 73.44

Competitive Comparison of Biofil Chemicals & Pharmaceuticals's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Biofil Chemicals & Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biofil Chemicals & Pharmaceuticals's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biofil Chemicals & Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Biofil Chemicals & Pharmaceuticals's Shiller PE Ratio falls into.



Biofil Chemicals & Pharmaceuticals Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Biofil Chemicals & Pharmaceuticals's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=67.40/0.74
=91.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biofil Chemicals & Pharmaceuticals's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Biofil Chemicals & Pharmaceuticals's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.06/153.2548*153.2548
=0.060

Current CPI (Dec. 2023) = 153.2548.

Biofil Chemicals & Pharmaceuticals Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.180 91.425 0.302
201406 0.031 94.103 0.050
201409 0.092 96.780 0.146
201412 0.013 96.780 0.021
201503 0.224 97.163 0.353
201506 0.000 99.841 0.000
201509 0.054 101.753 0.081
201512 0.075 102.901 0.112
201603 0.320 102.518 0.478
201606 0.020 105.961 0.029
201609 0.168 105.961 0.243
201612 0.302 105.196 0.440
201703 0.620 105.196 0.903
201706 0.060 107.109 0.086
201709 0.040 109.021 0.056
201712 0.140 109.404 0.196
201803 0.050 109.786 0.070
201806 0.040 111.317 0.055
201809 0.060 115.142 0.080
201812 0.180 115.142 0.240
201903 0.200 118.202 0.259
201906 0.020 120.880 0.025
201909 0.490 123.175 0.610
201912 0.140 126.235 0.170
202003 0.090 124.705 0.111
202006 0.130 127.000 0.157
202009 0.570 130.118 0.671
202012 0.310 130.889 0.363
202103 -0.250 131.771 -0.291
202106 0.110 134.084 0.126
202109 0.130 135.847 0.147
202112 0.210 138.161 0.233
202203 -0.010 138.822 -0.011
202206 0.130 142.347 0.140
202209 0.030 144.661 0.032
202212 0.060 145.763 0.063
202303 0.128 146.865 0.134
202306 0.150 150.280 0.153
202309 0.080 151.492 0.081
202312 0.060 153.255 0.060

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Biofil Chemicals & Pharmaceuticals  (BOM:524396) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Biofil Chemicals & Pharmaceuticals Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Biofil Chemicals & Pharmaceuticals's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Biofil Chemicals & Pharmaceuticals (BOM:524396) Business Description

Traded in Other Exchanges
Address
11/12, Sector E, Sanwer Road, Industrial Area, Indore, MP, IND, 452015
Biofil Chemicals & Pharmaceuticals Ltd is an Indian-based pharmaceutical company. The company's operating segment includes Pharma and Chemicals. It generates maximum revenue from the Pharma segment.

Biofil Chemicals & Pharmaceuticals (BOM:524396) Headlines

No Headlines